The future of aducanumab, Biogen’s treatment for Alzheimer’s disease, appears brighter after reviewers at the Food and Drug Administration indicated they believed the drug was sufficiently safe and effective.
Trending:
FDA scientists appear to offer major endorsement of aducanumab, Biogen's controversial Alzheimer's treatment